Back to 
Osaic Holdings, Inc.
Osaic Holdings, Inc.
CLDX
Showing 8 of 26 quarters
Position history for Osaic Holdings, Inc.'s holdings in Celldex Therapeutics, Inc.
Yes. Osaic Holdings holds 862 shares of CLDX (Celldex Therapeutics), worth $32,067, as of its Q2 2026 13F filing. It reduced the position by 90 shares (-9.5%) from Q1 2026. Osaic Holdings has held CLDX in every 13F on record since Q1 2020, 26 quarterly filings.
Current Value
$32,067
Current Shares
862
Total Value Change
+$15,381
Total Shares Change
+371
Quarter-by-Quarter History